pancrelipase
pancrelipase is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including PERTZYE. Available dosage form: capsule, delayed release.
Drug details
- Generic Name
- pancrelipase
- Brand Names
- PERTZYE
- Application Number
- BLA022175
- Sponsor
- Digestive Care, Inc.
- NDC Codes
- 4
- Dosage Forms
- CAPSULE, DELAYED RELEASE
- Routes
- ORAL
- Active Ingredients
- PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, PANCRELIPASE PROTEASE
Indications and Usage
1. INDICATIONS AND USAGE VIOKACE, in combination with a proton pump inhibitor, is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults. VIOKACE, in combination with a proton pump inhibitor, is indicated for the treatment of exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatectomy in adults. ( 1 )